Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
Recorded Q4'24 consolidated revenue of KRW 1.26 trillion Recorded FY'24 consolidated revenue of KRW 4.55 trillion Poised for further growth with expanded capacity and new service offerings INCHEON, South Korea, Jan. 22, 2025 /PRNewswire/ -- Samsung...
2025 Japan Prize Laureates Announced
TOKYO, Jan. 22, 2025 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2025 Japan prize on January 22, 2025. Prof. Russell Dean Dupuis of the USA has been awarded the Japan Prize in the fields of Materials Sciences and...
CP AXTRA Partners with Tencent Cloud: Catalysing a Digital Transformation in Retail
Newly signed agreement encompasses IaaS and artificial intelligence solutions to enhance customer experience, competitive edge and operational capabilities BANGKOK, Jan. 22, 2025 /PRNewswire/ -- Tencent Cloud and CP AXTRA unveiled a strategic...
Akeso Received Payment for the Development Collaboration on Tagitanlimab
HONG KONG, Jan. 22, 2025 /PRNewswire/ -- On January 22, 2025, Akeso Inc. (9926.HK) announced that it had received payment from Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. ("Sichuan Kelun") for their collaboration on the development of...
To answer three key questions about economic globalization
BEIJING, Jan. 22, 2025 /PRNewswire/ -- A report from People's Daily: In the face of a sluggish world economic recovery, the rising threat of protectionism, and the widening gap between the rich and the poor, discussions around economic globalization...
The 7th "HK Digital Advertising Start-ups X Publishing (Writers) Promotion Support Scheme"
Unveiling 12 Selected Teams of Local Digital Advertising Start-ups & Emerging Writers HONG KONG, Jan. 22, 2025 /PRNewswire/ -- The Hong Kong Digital Advertising Start-ups X Publishing (Writers) Promotion Support Scheme (the "Support Scheme"),...
PCX Markets Earns B Corp Certification
SINGAPORE, Jan. 22, 2025 /PRNewswire/ -- PCX Markets, a marketplace for audited, traceable plastic waste recovery and responsible processing, today announced that it has been certified as a B Corporation™ (B Corp™), further recognizing the company's...
Hyundai ADM Unveils a "New Paradigm in Cancer Treatment" - Preclinical Study Shows Promise for Continuous Oral Chemotherapy with Lowered Side Effects Risks
SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ -- Hyundai ADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug OTX-M, developed from the well-known injectable chemotherapy drug...